These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15783026)
1. Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma. Maeda T; Shimada M; Harimoto N; Tsujita E; Maehara S; Rikimaru T; Tanaka S; Shirabe K; Maehara Y Hepatogastroenterology; 2005; 52(61):187-90. PubMed ID: 15783026 [TBL] [Abstract][Full Text] [Related]
2. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287 [TBL] [Abstract][Full Text] [Related]
3. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [TBL] [Abstract][Full Text] [Related]
4. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
5. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395 [TBL] [Abstract][Full Text] [Related]
6. Vascular density and VEGF expression in hepatic lesions. Brodsky SV; Mendelev N; Melamed M; Ramaswamy G J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117 [TBL] [Abstract][Full Text] [Related]
7. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
8. Variation in the distribution of trace elements in hepatoma. Tashiro H; Kawamoto T; Okubo T; Koide O Biol Trace Elem Res; 2003 Oct; 95(1):49-63. PubMed ID: 14555799 [TBL] [Abstract][Full Text] [Related]
9. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis. Hu S; Zhang M; Lv Z; Bi J; Dong Y; Wen J Neoplasma; 2007; 54(3):207-11. PubMed ID: 17447851 [TBL] [Abstract][Full Text] [Related]
10. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Cu in hepatocellular carcinoma by particle induced X-ray emission. Jie J; Hao S; Hongxiu Y; Huiying Y; Jun M; Chenji W; Mingjie Y; Yong M J Trace Elem Med Biol; 2007; 21(4):255-60. PubMed ID: 17980816 [TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [TBL] [Abstract][Full Text] [Related]
13. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Liaw KY; Lee PH; Wu FC; Tsai JS; Lin-Shiau SY Am J Gastroenterol; 1997 Dec; 92(12):2260-3. PubMed ID: 9399766 [TBL] [Abstract][Full Text] [Related]
14. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity. Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286 [TBL] [Abstract][Full Text] [Related]
15. Decreased expressions of hepsin in human hepatocellular carcinomas. Chen CH; Su KY; Tao MH; Lin SW; Su YH; Tsai YC; Cheng KC; Jeng YM; Sheu JC Liver Int; 2006 Sep; 26(7):774-80. PubMed ID: 16911458 [TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma. Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309 [TBL] [Abstract][Full Text] [Related]
17. Distribution of metalloproteins in hepatocellular carcinoma and surrounding tissues. Liu Y; Li L; Gao Y; Chen C; Li B; He W; Huang Y; Chai Z Hepatogastroenterology; 2007 Dec; 54(80):2291-6. PubMed ID: 18265650 [TBL] [Abstract][Full Text] [Related]
18. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver. Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969 [TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver. Mun KS; Cheah PL; Baharudin NB; Looi LM Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794 [TBL] [Abstract][Full Text] [Related]
20. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]